<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9848">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01805505</url>
  </required_header>
  <id_info>
    <org_study_id>MAD-EH-01-2012-01</org_study_id>
    <nct_id>NCT01805505</nct_id>
  </id_info>
  <brief_title>Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound</brief_title>
  <official_title>Comparison of Embryo Transfer in Egg Donation Recipients With Transvaginal and Transabdominal Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IVI Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IVI Madrid</source>
  <oversight_info>
    <authority>Spain: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transabdominal ultrasound guidance is the golden standard for embryo transfers. Transvaginal
      ultrasound guidance was proposed recently to provide better visualization and reduce patient
      discomfort as embryo transfer can be performed with an empty bladder in this case. The
      purpose of this study is to determine whether there are any differences between transvaginal
      and transabdominal ultrasound-guided embryo transfer in terms of ease of use, patient
      satisfaction, and treatment outcome.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>At performing the pregnancy test 11 days post-embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
    <description>Proportion of patients with a positive pregnancy test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical pregnancy rate</measure>
    <time_frame>At first pregnancy ultrasound (3 weeks post-embryo transfer)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Proportion of patients with at least one gestational sac at first pregnancy ultrasound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rate</measure>
    <time_frame>At 10 weeks post-embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
    <description>Proportion of patients with at least one live intrauterine fetus at 10 weeks post-embryo transfer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Menstruation-like pain</measure>
    <time_frame>At embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured on a three-level scale (none/mild/strong)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Discomfort related to vesical distension</measure>
    <time_frame>At embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured on a three-level scale (none/mild/strong)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall discomfort</measure>
    <time_frame>At embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured on a three-level scale (none/mild/strong)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difficulty using the assigned technique faced by operators</measure>
    <time_frame>At embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured on a three-level scale (easy/moderately difficult/very difficult)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Catheterization time</measure>
    <time_frame>At embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conversion to the opposite technique</measure>
    <time_frame>At embryo transfer</time_frame>
    <safety_issue>No</safety_issue>
    <description>Proportion of cases in which embryo transfer was performed using the technique of the opposite randomization arm (i.e., proportion of patients randomized to have transabdominal ultrasound-guided transfer in whom transvaginal ultrasound-guided was performed, and the other way around)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">346</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Transvaginal ultrasound-guided embryo transfer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transvaginal ultrasound-guided transfer of two day-3 embryos</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transabdominal ultrasound-guided embryo transfer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Transabdominal ultrasound-guided transfer of two day-3 embryos</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transvaginal ultrasound-guided embryo transfer</intervention_name>
    <description>Embryo transfer of two day-3 embryos performed with the Kitazato Long ET catheter (Kitazato Medical Co. Ltd., Tokyo, Japan), guided by transvaginal ultrasound</description>
    <arm_group_label>Transvaginal ultrasound-guided embryo transfer</arm_group_label>
    <other_name>Kitazato Long ET catheter (Kitazato Medical Co. Ltd., Tokyo, Japan)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transabdominal ultrasound-guided embryo transfer</intervention_name>
    <description>Embryo transfer of two day-3 embryos performed with the Cook Soft-Trans ET catheter (Cook Medical Inc., Bloomington, IN, USA), guided by transabdominal ultrasound</description>
    <arm_group_label>Transabdominal ultrasound-guided embryo transfer</arm_group_label>
    <other_name>Cook Soft-Trans ET catheter (Cook Medical Inc., Bloomington, IN, USA)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing oocyte donation treatment with transfer of 2 embryos on day 3

        Exclusion Criteria:

          -  Submucous or &gt;3 cm intramural fibroids

          -  Turner syndrome

          -  Black recipients
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erik E Hauzman, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IVI Madrid</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juan A Garcia-Velasco, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>IVI Madrid</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erik E Hauzman, MD, PhD</last_name>
    <phone>+34 911 802 900</phone>
    <email>erik.hauzman@ivi.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>IVI Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28023</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 7, 2013</lastchanged_date>
  <firstreceived_date>March 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Female infertility</keyword>
  <keyword>Oocyte donation</keyword>
  <keyword>Embryo transfer</keyword>
  <keyword>Transvaginal ultrasonography</keyword>
  <keyword>Transabdominal ultrasonography</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
